Haemonetics Enters Whole Blood Collection Market With Sebra Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Haemonetics will gain a presence in the whole blood collection market through its acquisition of Sebra's biological collection and processing division for $12.5 million, announced Sept. 8